Affymax plunges 85% on recall of anemia drug


Feb 27, 2013

Shares of Affymax Inc. plummeted more than 85% Monday after the company recalled its antianemia drug Omontys following a handful of fatal reactions that followed use of the medication in first-time users. Read the full story here. 
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments